Hyundai Bioscience

048410.KQ

5.16 USD

-0.29

-5.32%

Overview

Last close

5.16 usd

Market cap

497.62M usd

52 week high

13.86 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

201.6818

Price/Book Value

6.3989

Enterprise Value

477.15M usd

EV/Revenue

193.1096

EV/EBITDA

-64.6317

Key financials

Revenue TTM

2.47M usd

Gross Profit TTM

-186492.68 usd

EBITDA TTM

-13.30M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

84.85M usd

Net debt

2.74M usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.